Science Explorer Back to mapMap

Most cited papers from G1 Therapeutics (United States)

What are the most cited papers from G1 Therapeutics (United States)?

The most cited paper from G1 Therapeutics (United States) is "Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension" (Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al., 2002), with 831 citations. Next come "CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation" (801) and "Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification" (370).

Showing 50 of 60 papers. Every paper with more than 23 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al. · Journal of the American College of Cardiology Open access Apr 2002 831
2 CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation Jiehui Deng et al. · Cancer Discovery Open access 3 Nov 2017 801
3 Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification Patrick J. Roberts, Natalia Mitin, Patricia J. Keller et al. · Journal of Biological Chemistry Open access 10 Jul 2008 370
4 Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector Joshua C. Grieger, Stephen Soltys, Richard Jude Samulski · Molecular Therapy Open access 6 Oct 2015 327
5 Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo Christopher C. Nixon et al. · Nature Open access 22 Jan 2020 323
6 Manufacturing of recombinant adeno-associated viral vectors for clinical trials Nathalie Clément, Joshua C. Grieger · Molecular Therapy — Methods & Clinical Development Open access 2016 293
7 Perception of Chemotherapy Side Effects Cancer versus Noncancer Patients Celeste M Lindley, Jeannine S. McCune, Tracy E. Thomason et al. · Cancer Practice Mar 1999 217
8 Dry Powder Inhalers: An Overview Paul J. Atkins · Respiratory Care Oct 2005 182
9 Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial J.M. Weiss et al. · Annals of Oncology Open access 22 Aug 2019 174
10 Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer Craig M. Goodwin et al. · Cancer Research Open access 8 Nov 2022 171
11 Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension Alan L. Hinderliter, Park W. Willis, Walker A. Long et al. · The American Journal of Cardiology Aug 1999 164
12 Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project Bennett S. Levitan, Kenneth A. Getz, Eric L. Eisenstein et al. · Therapeutic Innovation & Regulatory Science Open access 20 Jul 2017 161
13 Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion Shenghui He, Patrick J. Roberts, Jessica A. Sorrentino et al. · Science Translational Medicine Open access 26 Apr 2017 160
14 Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis Paolo Raggi, Antonio Bellasi, David A. Bushinsky et al. · Circulation Open access 11 Nov 2019 154
15 Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits Bryan C. Quach et al. · Nature Communications Open access 3 Nov 2020 133
16 Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression John Bisi, Jessica A. Sorrentino, Patrick J. Roberts et al. · Molecular Cancer Therapeutics 29 Jan 2016 127
17 CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury Derek P. DiRocco, John Bisi, Patrick J. Roberts et al. · American Journal of Physiology-Renal Physiology Open access 12 Dec 2013 126
18 Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study Lowell L. Hart, Renata Ferrarotto, Zoran Gojko Andric et al. · Advances in Therapy Open access 29 Oct 2020 125
19 Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial Antoinette R. Tan, Gail Shaw Wright, Anu R. Thummala et al. · The Lancet Oncology 28 Sep 2019 117
20 From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases Ian Douglas Pavord, Elisabeth H. Bel, Arnaud Bourdin et al. · Allergy Open access 17 Aug 2021 116
21 Herpesvirus Infection Accelerates Atherosclerosis in the Apolipoprotein E–Deficient Mouse Dagmar Alber, Kenneth L. Powell, Patrick J. Vallance et al. · Circulation Open access 15 Aug 2000 106
22 Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors Robert S. Epstein, Matti Aapro, Upal Kunal Basu Roy et al. · Advances in Therapy Open access 8 Jul 2020 105
23 Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing Shaunak Sanjay Adkar, Chia‐Lung Wu, Vincent P. Willard et al. · Stem Cells Open access 31 Oct 2018 105
24 CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy Anne Y. Lai, Jessica A. Sorrentino, Konstantin H. Dragnev et al. · Journal for ImmunoTherapy of Cancer Open access Oct 2020 92
25 Design of anti-inflammatory heparan sulfate to protect against acetaminophen-induced acute liver failure Katelyn Arnold et al. · Science Translational Medicine Open access 18 Mar 2020 90
26 Guideline‐Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure Richard H. Tran, Ahmed Mohammed Aldemerdash, Patricia P. Chang et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy Open access 9 Feb 2018 90
27 Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial Davey B. Daniel, Vladimer Kuchava, Igor Bondarenko et al. · International Journal of Cancer Open access 22 Dec 2020 85
28 Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension Alan L. Hinderliter, Park W. Willis, Walker A. Long et al. · The American Journal of Cardiology Apr 2003 85
29 Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies Jared Weiss, Jerome H. Goldschmidt, Zoran Gojko Andric et al. · Clinical Lung Cancer Open access 26 Mar 2021 71
30 A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma Dave Singh, Rainard Fuhr, Nicholas Bird et al. · British Journal of Clinical Pharmacology Open access 22 Jul 2021 69
31 Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Chronic Low Back Pain Provides Sustained Relief Christopher A Gilmore, Leonardo Kapural, Meredith J. McGee et al. · Neuromodulation Technology at the Neural Interface 5 Oct 2018 66
32 Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows Patrick J. Roberts, Vishnu Muthuraj Kumarasamy, Agnieszka Katarzyna Witkiewicz et al. · Molecular Cancer Therapeutics Open access 16 Jun 2020 63
33 Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors John Bisi, Jessica A. Sorrentino, Jamie L. Jordan et al. · Oncotarget Open access 15 Mar 2017 61
34 Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA ® Dry Powder Inhaler David Prime, Wilfried De Backer, Melanie Hamilton et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 15 Sep 2015 60
35 IGSF8 is an innate immune checkpoint and cancer immunotherapy target Yulong Li et al. · Cell Open access 23 Apr 2024 56
36 Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay et al. · Cancer Medicine Open access 18 Aug 2021 50
37 CDK4/6 Therapeutic Intervention and Viable Alternative to Taxanes in CRPC James P. Stice, Suzanne E. Wardell, John D. Norris et al. · Molecular Cancer Research Open access 16 Feb 2017 50
38 G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer Kaitlyn J. Andreano, Suzanne E. Wardell, Jennifer G. Baker et al. · Breast Cancer Research and Treatment Open access 4 Mar 2020 47
39 A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD Gregory Feldman, François Maltais, Sanjeev K. Khindri et al. · International Journal of COPD Open access Apr 2016 47
40 Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy Is Demonstrated by Collaborative Pooling of Data From Clinical Trials Conducted by Multiple Sponsors John A. Wagner, Elizabeth Cox Wright, Marguerite Ennis et al. · Clinical Pharmacology & Therapeutics 24 Jun 2009 44
41 Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study Antoinette R. Tan, Gail Shaw Wright, Anu R. Thummala et al. · Clinical Cancer Research Open access 6 Dec 2021 43
42 Real-world burden of chemotherapy-induced myelosuppression in patients with small cell lung cancer: a retrospective analysis of electronic medical data from community cancer care providers Robert S. Epstein, Roshanthi K. Weerasinghe, Amy S. Parrish et al. · Journal of Medical Economics Open access 20 Dec 2021 42
43 Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life Robert S. Epstein, Upal Kunal Basu Roy, Matti Aapro et al. · Patient Preference and Adherence Open access Feb 2021 41
44 Randomized Trial of Clitoral Vacuum Suction Versus Vibratory Stimulation in Neurogenic Female Orgasmic Dysfunction Marcalee Sipski Alexander, Khurram Bashir, Craig J. Alexander et al. · Archives of Physical Medicine and Rehabilitation 9 Sep 2017 36
45 [18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant Ramsha Iqbal, Maqsood M. Yaqub, Huseyyin O. Bektas et al. · Clinical Cancer Research Open access 3 Feb 2023 35
46 Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype Benjamin Terrier, David R.W. Jayne, Bernhard Hellmich et al. · ACR Open Rheumatology Open access 13 Jun 2023 34
47 Percutaneous Peripheral Nerve Stimulation for the Treatment of Chronic Low Back Pain: Two Clinical Case Reports of Sustained Pain Relief Leonardo Kapural, Christopher A Gilmore, John Chae et al. · Pain Practice 14 Mar 2017 33
48 Glucose and lipid effects of the ileal apical sodium‐dependent bile acid transporter inhibitor GSK2330672 : double‐blind randomized trials with type 2 diabetes subjects taking metformin Derek J. Nunez, Xiaozhou Yao, Jian Lin et al. · Diabetes Obesity and Metabolism 5 Mar 2016 33
49 Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial Hypertension R. James White, Fernando Torres, Roblee P. Allen et al. · Journal of Cardiovascular Pharmacology 17 Jan 2013 32
50 Initial locomotor sensitivity to cocaine varies widely among inbred mouse strains Tim Wiltshire, Robin Ervin, Huicun Duan et al. · Genes Brain & Behavior Open access Mar 2015 32

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.